Evidence map›Paper›PMID 42084917›Full record

ArticleJCI insight2026

Pulmonary fibroblast subsets demonstrate differentially enriched signaling pathways during fibrosis resolution and repair.

Daniel G Foster, Nomin Javkhlan, Bart P Black, Brian E Vestal, David Wh Riches, Elizabeth F Redente

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel G FosterDepartment of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, Colorado, USA.
Nomin JavkhlanDepartment of Pediatrics, and.
Bart P BlackDepartment of Pediatrics, and.
Brian E VestalCenter for Genes, Environment and Health, National Jewish Health, Denver, Colorado, USA.
David Wh RichesDepartment of Pediatrics, and.
Elizabeth F RedenteDepartment of Pharmaceutical Sciences, University of Colorado School of Pharmacy, Aurora, Colorado, USA.

Funding

Roles for interstitial and airspace macrophages in resolution of pulmonary inflammationR01HL149741 · NHLBI · NATIONAL JEWISH HEALTH · PI HENSON, PETER M, REDENTE, ELIZABETH FRANCES · 2020 to 2023
$3.0M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of ResolutionR01HL147860 · NHLBI · NATIONAL JEWISH HEALTH · PI REDENTE, ELIZABETH FRANCES · 2019 to 2023
$2.7M
Fibroblast Resistance to Apoptosis in Pulmonary FibrosisR01HL140595 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHES, DAVID W. · 2018 to 2021
$2.5M
Targeted Death of Collagen1a1-Expressing Fibroblasts Reduces Silica-Induced Pulmonary FibrosisF31HL170750 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FOSTER, DANIEL G · 2023 to 2025
$102k
Targeting Bcl-2 Family Proteins to Facilitate Fibroblast Apoptosis and Promote the Resolution of Pulmonary FibrosisF32HL156281 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI COOLEY, JOSEPH CHARLES · 2021 to 2022
$82k
BLRD VA I01 BX003471NCATS NIH HHS TL1 TR002533NHLBI NIH HHS F31 HL170750NHLBI NIH HHS F32 HL156281NHLBI NIH HHS R01 HL140595NHLBI NIH HHS R01 HL147860NHLBI NIH HHS R01 HL149741
6 · The paper itself

Abstract

The lungs have a remarkable capacity to undergo homoeostatic repair and regeneration after injury, which often occurs in patients with acute respiratory distress syndrome (ARDS) and in the single-dose bleomycin mouse model. Fibroblasts are critical mediators of fibrotic disease and RNA sequencing has identified significant heterogeneity within pulmonary fibroblast populations. However, the contribution of distinct fibroblast subsets to the repair process has been understudied compared with their role in fibrosis initiation and progression. Therefore, we sought to define the transcriptional landscape of 3 phenotypically defined fibroblast subsets that occupy discrete spatial locations in naive lungs. Using TdTomato-lineage tracing approaches, we identified and interrogated collagen1a1+ (Col1a1) fibroblasts, perilipin 2+ (Plin2) alveolar fibroblasts, and α-smooth muscle actin+ (Acta2) myofibroblasts during fibrosis development and resolution after single-dose bleomycin. Quantification of fibroblast numbers showed that all 3 subsets expanded during fibrosis and contracted toward naive levels with resolution. Principal component and gene set enrichment analyses indicate that each subset underwent major transcriptomic shifts during fibrosis development, converging on a similar profibrotic transcriptional profile. However, during resolution, Plin2+ and Acta2+ fibroblasts reverted toward a prefibrotic transcriptional state, whereas Col1a1+ fibroblasts acquired a distinct program that suggests an active role in mediating the repair processes.

Indexed as

FibroblastsLungPulmonary FibrosisSignal TransductionActinsAnimalsBleomycinCollagen Type ICollagen Type I, alpha 1 ChainDisease Models, AnimalMiceMyofibroblastsTranscriptomeActinsBleomycinCollagen Type ICollagen Type I, alpha 1 ChainCell biologyFibrosisMolecular geneticsPulmonology

Identifiers

PMID42084917
PMCPMC13460824

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.